DA
ABBV icon

DCM Advisors’s AbbVie ABBV Stock Holding History

DCM Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6M Sell
27,604
-234
-0.8% -$51.9K 2.73% 19
2025
Q4 		$6.36M Hold
27,838
– – 2.64% 18
2025
Q3 		$6.45M Sell
27,838
-77
-0.3% -$15.7K 2.72% 17
2025
Q2 		$5.18M Buy
27,915
+2,059
+8% +$383K 2.22% 21
2025
Q1 		$5.41M Sell
25,856
-3,017
-10% -$587K 2.89% 15
2024
Q4 		$5.13M Buy
28,873
+1,078
+4% +$198K 2.41% 17
2024
Q3 		$5.49M Hold
27,795
– – 2.77% 16
2024
Q2 		$4.77M Sell
27,795
-4,486
-14% -$743K 2.52% 19
2024
Q1 		$5.88M Sell
32,281
-7,804
-19% -$1.34M 2.42% 18
2023
Q4 		$6.21M Buy
40,085
+5,447
+16% +$794K 2.23% 19
2023
Q3 		$5.16M Sell
34,638
-949
-3% -$139K 2.33% 18
2023
Q2 		$4.79M Buy
35,587
+488
+1% +$71.6K 2.05% 18
2023
Q1 		$5.59M Sell
35,099
-263
-0.7% -$40.2K 2.6% 16
2022
Q4 		$5.71M Buy
35,362
+13,725
+63% +$2.1M 2.77% 15
2022
Q3 		$2.9M Sell
21,637
-377
-2% -$54.1K 1.46% 14
2022
Q2 		$3.37M Buy
22,014
+1,040
+5% +$159K 1.46% 12
2022
Q1 		$3.4M Sell
20,974
-220
-1% -$32K 1.2% 18
2021
Q4 		$2.87M Buy
21,194
+9,910
+88% +$1.17M 0.85% 29
2021
Q3 		$1.22M Buy
+11,284
New +$1.29M 0.47% 56

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM Advisors's ABBV Position: Q1 2026 in Review

DCM Advisors reduced its AbbVie (ABBV) stake by 0.84% in Q1 2026, selling an estimated $51.9K and leaving 27,604 shares worth $6M. The position accounts for 2.73% of the portfolio, ranked #19.

DCM Advisors first reported a position in ABBV in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.45M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DCM Advisors held 27,604 shares of AbbVie worth $6M as of Q1 2026.
  • DCM Advisors sold 234 AbbVie shares in Q1 2026, an estimated $51.9K.
  • AbbVie made up 2.73% of DCM Advisors's portfolio in Q1 2026, its #19 holding.
  • DCM Advisors first reported a position in AbbVie in Q3 2021 and has held it in 19 quarters since.
  • DCM Advisors's AbbVie position peaked at $6.45M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DCM Advisors's 13F filing for Q1 2026, filed 15 May 2026.